中国卫生标准管理
中國衛生標準管理
중국위생표준관리
CHINA HEALTH STANDARD MANAGEMENT
2015年
7期
253-254
,共2页
肠炎康胶囊%溃疡性结肠炎%临床观察
腸炎康膠囊%潰瘍性結腸炎%臨床觀察
장염강효낭%궤양성결장염%림상관찰
Changyankang capsule%Ulcerative colitis%Clinical observation
目的:探讨肠炎康胶囊治疗溃疡性结肠炎112例的临床疗效。方法选取2013年9月~2014年2月于本院收治的溃疡性结肠炎患者112例,作为研究对象。依据随机原则将患者分为观察组和对照组各56例,对照组:让患者口服柳氮磺胺吡啶(SASP);观察组:饭前保持空腹,让患者口服肠炎康胶囊3粒。结果比较观察组和对照组临床疗效,综合得出观察组总有效率(100%)高于对照组总有效率(83.9%),指标的组间差异有统计学意义(P<0.05)。结论使用肠炎康胶囊治疗溃疡性结肠炎患者,具有疗效快,便捷,无不良临床反应等多项特点。
目的:探討腸炎康膠囊治療潰瘍性結腸炎112例的臨床療效。方法選取2013年9月~2014年2月于本院收治的潰瘍性結腸炎患者112例,作為研究對象。依據隨機原則將患者分為觀察組和對照組各56例,對照組:讓患者口服柳氮磺胺吡啶(SASP);觀察組:飯前保持空腹,讓患者口服腸炎康膠囊3粒。結果比較觀察組和對照組臨床療效,綜閤得齣觀察組總有效率(100%)高于對照組總有效率(83.9%),指標的組間差異有統計學意義(P<0.05)。結論使用腸炎康膠囊治療潰瘍性結腸炎患者,具有療效快,便捷,無不良臨床反應等多項特點。
목적:탐토장염강효낭치료궤양성결장염112례적림상료효。방법선취2013년9월~2014년2월우본원수치적궤양성결장염환자112례,작위연구대상。의거수궤원칙장환자분위관찰조화대조조각56례,대조조:양환자구복류담광알필정(SASP);관찰조:반전보지공복,양환자구복장염강효낭3립。결과비교관찰조화대조조림상료효,종합득출관찰조총유효솔(100%)고우대조조총유효솔(83.9%),지표적조간차이유통계학의의(P<0.05)。결론사용장염강효낭치료궤양성결장염환자,구유료효쾌,편첩,무불량림상반응등다항특점。
Objective To investigate the clinical observation on 112 cases with ulcerative colitis treated by changyankang capsule. Methods Chose 112 patients with ulcerative colitis treated in our hospital from September 2013 to February 2014 as the research objects. Patients were divided into observation group and control group randomly with 56 cases in each group,the control group: giving patient oral Salicylazosulfapyridine(SASP), observation group: keeping fasting before meals,then giving patients oral changyankang capsule 3 grain. Results Compared the clinical efficacy in two groups,and concluded that the total effective rate of observation group(100%)was higher than that in the control group(83.9%), there was a significant difference between the two groups(P<0.05). Conclusion The use of Changyankang capsule in the treatment of patients with ulcerative colitis,has curative effect fast,convenient,no adverse clinical reactions.